タンパク質シーケンシングの世界市場予測（～2023年）...市場調査レポートについてご紹介

TABLE OF CONTENTS

1 INTRODUCTION 15
1.1 OBJECTIVES OF THE STUDY 15
1.2 MARKET DEFINITION 15
1.3 MARKET SCOPE 16
1.3.1 MARKETS COVERED 16
1.3.2 YEARS CONSIDERED FOR THE STUDY 17
1.4 CURRENCY 17
1.5 LIMITATIONS 18
1.6 STAKEHOLDERS 18
2 RESEARCH METHODOLOGY 19
2.1 RESEARCH DATA 19
2.1.1 SECONDARY RESEARCH 20
2.1.1.1 Key data from secondary sources 20
2.1.2 PRIMARY RESEARCH 20
2.1.2.1 Key data from primary sources 21
2.1.2.1.1 Breakdown of Primary Interviews 21
2.2 MARKET SIZE ESTIMATION 22
2.2.1 REVENUE-BASED MARKET ESTIMATION 22
2.2.2 END-USER-BASED MARKET ESTIMATION 22
2.2.3 PRIMARY RESEARCH VALIDATION 23
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 24
2.4 ASSUMPTIONS FOR THE STUDY 25
3 EXECUTIVE SUMMARY 26
4 PREMIUM INSIGHTS 30
4.1 PROTEIN SEQUENCING MARKET OVERVIEW 30
4.2 PROTEIN SEQUENCING MARKET, BY PRODUCT & SERVICE (2018 VS. 2023) 30
4.3 PROTEIN SEQUENCING MARKET, BY TECHNOLOGY, 2018 VS. 2023 31
4.4 PROTEIN SEQUENCING MARKET, BY APPLICATION, 2018 VS. 2023 31
4.5 PROTEIN SEQUENCING MARKET, BY END USER, 2018 VS. 2023 32
 
5 MARKET OVERVIEW 33
5.1 INTRODUCTION 33
5.2 MARKET DYNAMICS 33
5.2.1 DRIVERS 34
5.2.1.1 Increasing focus on target-based drug development by pharmaceutical and biotechnology companies 34
5.2.1.2 Advancements in clinical mass spectrometry and analytical techniques 34
5.2.1.3 Increasing public-private financial support for proteomic research 34
5.2.2 RESTRAINTS 35
5.2.2.1 High infrastructure costs 35
5.2.3 OPPORTUNITIES 36
5.2.3.1 Technological advancements for the identification of isobaric residues in protein sequences 36
5.2.4 CHALLENGES 36
5.2.4.1 Preparation of pure protein samples 36
5.2.4.2 Need for skilled researchers and laboratory professionals 36
6 PROTEIN SEQUENCING MARKET, BY PRODUCT & SERVICE 37
6.1 INTRODUCTION 38
6.2 SAMPLE PREPARATION PRODUCTS & SERVICES 39
6.2.1 GROWING NEED FOR STANDARDIZED SAMPLE PREPARATION SOLUTIONS IS A MAJOR DRIVER FOR THE SAMPLE PREPARATION PRODUCTS & SERVICES MARKET 39
6.3 PROTEIN SEQUENCING PRODUCTS 40
6.3.1 REAGENTS & CONSUMABLES 41
6.3.1.1 Growing number of sequencing procedures to drive the demand for protein sequencing reagents & consumables 41
6.3.2 INSTRUMENTS 41
6.3.2.1 Mass spectrometry instruments 42
6.3.2.1.1 Technological advancements to drive the adoption of mass spectrometry instruments 42
6.3.2.2 Edman degradation sequencers 43
6.3.2.2.1 High accuracy of Edman degradation method to drive the adoption of these products 43
6.3.3 ANALYSIS PRODUCTS/SOFTWARE 44
6.3.3.1 Protein sequencing analysis products/software to witness the highest growth rate during the forecast period 44
6.4 PROTEIN SEQUENCING SERVICES 45
6.4.1 PROTEIN SEQUENCING SERVICES TO REGISTER THE HIGHEST GROWTH BETWEEN 2018 & 2023 45
 
7 PROTEIN SEQUENCING MARKET, BY TECHNOLOGY 46
7.1 INTRODUCTION 47
7.2 MASS SPECTROMETRY 48
7.2.1 HIGH-THROUGHPUT SEQUENCING CAPABILITIES AND COST EFFICIENCY TO DRIVE THE ADOPTION OF MASS SPECTROMETRY PROTEIN SEQUENCING 48
7.3 EDMAN DEGRADATION 49
7.3.1 HIGH ACCURACY OF THE EDMAN DEGRADATION METHOD IS THE KEY FACTOR DRIVING ITS ADOPTION IN THE MARKET 49
8 PROTEIN SEQUENCING MARKET, BY APPLICATION 50
8.1 INTRODUCTION 51
8.2 BIOTHERAPEUTICS 52
8.2.1 BIOTHERAPEUTICS SEGMENT TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD 52
8.3 GENETIC ENGINEERING 52
8.3.1 LARGE NUMBER OF RESEARCH PROJECTS FOCUSED ON GENETICALLY MODIFIED ORGANISMS & TECHNOLOGICAL ADVANCEMENTS—KEY FACTORS DRIVING MARKET GROWTH 52
8.4 OTHER APPLICATIONS 54
9 PROTEIN SEQUENCING MARKET, BY END USER 56
9.1 INTRODUCTION 57
9.2 ACADEMIC INSTITUTES & RESEARCH CENTERS 58
9.2.1 ACADEMIC INSTITUTES & RESEARCH CENTERS TO ACCOUNT FOR THE LARGEST SHARE OF THE MARKET OWING TO THE INCREASING FUNDING FOR PROTEOMICS RESEARCH 58
9.3 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 60
9.3.1 INCREASING R&D EXPENDITURE OF MAJOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES TO DRIVE MARKET GROWTH 60
9.4 OTHER END USERS 61
10 PROTEIN SEQUENCING MARKET, BY REGION 62
10.1 INTRODUCTION 63
10.2 NORTH AMERICA 64
10.2.1 US 67
10.2.1.1 Launch of advanced protein sequencing products & the strong presence of leading players are driving the growth of the protein sequencing market in the US 67
10.2.2 CANADA 68
10.2.2.1 Financial support from government and private organizations for R&D in the proteomics field—major factor supporting market growth 68
10.3 EUROPE 69
10.3.1 GERMANY 72
10.3.1.1 Favorable funding scenario for life science research to drive the growth of the protein sequencing market in Germany 72
10.3.2 FRANCE 72
10.3.2.1 Rising demand for biotherapeutics and biotechnology in the country to drive the adoption of protein sequencing 72
10.3.3 UK 73
10.3.3.1 Presence of a large life sciences industry and the continued growth of the biopharmaceuticals sector are the major factors driving market growth 73
10.3.4 REST OF EUROPE 74
10.4 ASIA PACIFIC 75
10.4.1 CHINA 78
10.4.1.1 China to register the highest growth in the Asia Pacific protein sequencing market during the forecast period 78
10.4.2 JAPAN 78
10.4.2.1 Strong life sciences R&D infrastructure and a favorable government funding scenario are key factors driving market growth 78
10.4.3 INDIA 79
10.4.3.1 Implementation of favorable government initiatives to support life sciences research to support the growth of the protein sequencing market in India 79
10.4.4 REST OF ASIA PACIFIC 80
10.5 REST OF THE WORLD 81
11 COMPETITIVE LANDSCAPE 84
11.1 OVERVIEW 84
11.2 MARKET SHARE ANALYSIS 85
11.3 COMPETITIVE SITUATION AND TRENDS 86
11.3.1 PRODUCT LAUNCHES AND SERVICES 86
11.3.2 PARTNERSHIPS 87
11.3.3 ACQUISITIONS 87
11.3.4 EXPANSIONS 88
12 COMPANY PROFILES 89

(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
12.1 AGILENT TECHNOLOGIES, INC. 89
12.2 BIOINFORMATICS SOLUTIONS 91
12.3 CHARLES RIVER LABORATORIES 92
12.4 PROTEOME FACTORY 94
12.5 RAPID NOVOR INC. 95
12.6 SELVITA 97
12.7 SGS 99
 
12.8 SHIMADZU CORPORATION 101
12.9 THERMO FISHER SCIENTIFIC INC. 105
12.10 WATERS 109

*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.
13 APPENDIX 111
13.1 DISCUSSION GUIDE 111
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 115
13.3 AVAILABLE CUSTOMIZATIONS 117
13.4 RELATED REPORTS 117
13.5 AUTHOR DETAILS 118